Jacky Luiten

Trends in frequency and outcome of high‐risk breast lesions at CNB |63 4 20. Sen LQ, Berg WA, Hooley RJ, et al. Core breast biopsies showing lobular carcinoma in situ should be excised and surveillance is reasonable for atypical lobular hyperplasia. Am J Roentgenol 2016;207:1132–1145. 21. Mooney KL, Bassett LW, Apple SK. Upgrade rates of high‐risk breast lesions diagnosed on core needle biopsy: a single‐institution experience and literature review. Mod Pathol 2016;29: 1471‐1484. 22. Donaldson AR, Sieck L, Booth CN, et al. Radial scars diagnosed on breast core biopsy: frequency of atypia and carcinoma on excision and implications for management. Breast (Edinburgh, Scotland) 2016;30:201–207. 23. Rudin AV, Hoskin TL, Fahy A, et al. Flat epithelial Atypia on Core biopsy and upgrade to cancer: a systematic review and meta‐analysis. Ann Surg Oncol 2017;24:3549–3558. 24. Ouldamer L, Poisson E, Arbion F, et al. All pure flat atypical atypia lesions of the breast diagnosed using percutaneous vacuum‐assisted breast biopsy do not need surgical excision. Breast (Edinburgh, Scotland). 2018;40:4–9. 25. Speer ME, Huang ML, Dogan BE, et al. High risk breast lesions identified on MRI‐guided vacuumassisted needle biopsy: outcome of surgical excision and imaging follow‐up. Br J Radiol 2018;91:20180300. 26. Chou WYY, Veis DJ, Aft R. Radial scar on imageguided breast biopsy: is surgical excision necessary? Breast Cancer Res Treat 2018;170:313–320. 27. van Breest Smallenburg V, Duijm LE, Voogd AC, et al. Lower sensitivity of screening mammography after previous benign breast surgery. Int J Cancer 2012;130:122–128. 28. Elshof LE, Tryfonidis K, Slaets L, et al. Feasibility of a prospective, randomised, open‐label, international multicentre, phase III, non‐inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ—the LORD study. Eur J Cancer 2015;51:1497–1510. 29. Francis A, Thomas J, Fallowfield L, et al. Addressing overtreatment of screen‐detected DCIS; the LORIS trial. Eur J Cancer 2015;51:2296–2303. 30. Rageth CJ, O’Flynn EA, Comstock C, et al. First international consensus conference on lesions of uncertain malignant potential in the breast (B3 lesions). Breast Cancer Res Treat 2016;159: 203‐213. 31. Pieri A, Hemming D, Westgarth J, et al. Vacuumassisted biopsy is a viable alternative to surgical biopsy in the investigation of breast lesions of uncertain malignant potential. Surgeon 2017;15: 59–64. 32. Rageth CJ, O’Flynn EAM, Pinker K, et al. Second international consensus conference on lesions of uncertain malignant potential in the breast (B3 lesions). Breast Cancer Res Treat 2019;174: 279‐296.